<code id='FB53FCEE70'></code><style id='FB53FCEE70'></style>
    • <acronym id='FB53FCEE70'></acronym>
      <center id='FB53FCEE70'><center id='FB53FCEE70'><tfoot id='FB53FCEE70'></tfoot></center><abbr id='FB53FCEE70'><dir id='FB53FCEE70'><tfoot id='FB53FCEE70'></tfoot><noframes id='FB53FCEE70'>

    • <optgroup id='FB53FCEE70'><strike id='FB53FCEE70'><sup id='FB53FCEE70'></sup></strike><code id='FB53FCEE70'></code></optgroup>
        1. <b id='FB53FCEE70'><label id='FB53FCEE70'><select id='FB53FCEE70'><dt id='FB53FCEE70'><span id='FB53FCEE70'></span></dt></select></label></b><u id='FB53FCEE70'></u>
          <i id='FB53FCEE70'><strike id='FB53FCEE70'><tt id='FB53FCEE70'><pre id='FB53FCEE70'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:5
          Adam's take main illustration
          Molly Ferguson/STAT

          Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics:

          A take-under deal feels meh for biotech sector sentiment.Bristol is paying $58 per share in cash for Mirati, which closed Friday at $60. Granted, Mirati was trading in the $30 range in September, so from there, the roughly 50% premium isn’t terrible. But as Mizuho strategist Jared Holz pointed out, investors would liked to have seen Mirati go for $75-$100 per share.

          advertisement

          With the closely watched XBI biotech index down 13% for the year, every M&A deal helps improve sentiment, but this one — maybe just a little. Bristol is paying $4.8 billion in cash to acquire Mirati, or $3.7 billion after accounting for Mirati’s cash. It’s a small bolt-on acquisition for Bristol, which isn’t overpaying.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Abortion pill mifepristone to soon be dispensed at CVS, Walgreens
          Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

          BoxesofmifepristoneAllenG.Breed/APThedrugstorechainsCVSHealthandWalgreensplantostartdispensingan abo

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

          FILE-RichardMoore,theChiefofBritain'sSecretIntelligenceService,alsoknownasMI6,answersquestionsafterg